Wall Street Zen Downgrades Aytu BioPharma (NASDAQ:AYTU) to Hold

Aytu BioPharma (NASDAQ:AYTU – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday. Other analysts also recently issued reports about the stock. Ascendiant Capital Markets boosted their price target on shares of Aytu […]

Leave a Reply

Your email address will not be published.

Previous post Roth Capital Comments on Uranium Energy Q1 Earnings
Next post Evercore ISI Cuts Costco Wholesale (NASDAQ:COST) Price Target to $1,025.00